A detailed history of Castleark Management LLC transactions in Insmed Inc stock. As of the latest transaction made, Castleark Management LLC holds 43,300 shares of INSM stock, worth $3.2 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
43,300
Previous 16,660 159.9%
Holding current value
$3.2 Million
Previous $1.12 Million 183.15%
% of portfolio
0.13%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$62.0 - $79.01 $1.65 Million - $2.1 Million
26,640 Added 159.9%
43,300 $3.16 Million
Q2 2024

Aug 13, 2024

BUY
$22.0 - $69.71 $366,520 - $1.16 Million
16,660 New
16,660 $1.12 Million
Q3 2022

Nov 15, 2022

BUY
$20.88 - $28.21 $1.34 Million - $1.81 Million
64,060 Added 38.98%
228,410 $4.92 Million
Q2 2022

Aug 16, 2022

SELL
$17.07 - $25.71 $74,595 - $112,352
-4,370 Reduced 2.59%
164,350 $3.24 Million
Q1 2022

May 16, 2022

BUY
$20.42 - $28.13 $3.45 Million - $4.75 Million
168,720 New
168,720 $3.97 Million
Q2 2021

Aug 17, 2021

SELL
$24.17 - $36.01 $5.05 Million - $7.53 Million
-209,103 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$32.28 - $44.3 $156,073 - $214,190
4,835 Added 2.37%
209,103 $7.12 Million
Q4 2020

Feb 17, 2021

SELL
$31.45 - $40.54 $1.35 Million - $1.74 Million
-42,900 Reduced 17.36%
204,268 $6.8 Million
Q3 2020

Nov 16, 2020

BUY
$26.0 - $34.5 $1.16 Million - $1.54 Million
44,593 Added 22.01%
247,168 $7.94 Million
Q2 2020

Aug 14, 2020

BUY
$14.11 - $29.42 $2.86 Million - $5.96 Million
202,575 New
202,575 $5.58 Million
Q3 2019

Nov 15, 2019

SELL
$15.49 - $25.78 $4.4 Million - $7.33 Million
-284,297 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$23.0 - $32.19 $825,585 - $1.16 Million
35,895 Added 14.45%
284,297 $7.28 Million
Q1 2019

May 14, 2019

BUY
$13.91 - $31.15 $3.46 Million - $7.74 Million
248,402 New
248,402 $7.22 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.